Senior insider sale
President and COO at BICARA THERAPEUTICS INC. — senior position signals high conviction
$1.17M
58.52K shares
What this filing means
COHLHEPP RYAN plans to sell 58.52K shares of BICARA THERAPEUTICS INC. valued at approximately $1.17M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/15/2026ACC: 0001969223-26-000560
DirectorOfficer· President and COO
Since Mar 2026
58.52K
Shares to sell
$1.17M
Approx. market value
12.50K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Option
Cash
5/15/2026
8KExercise of Stock Option
Cash
5/12/2024
4.50KTotal acquired12.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Exercise of Stock Option Cash | 8K | — |
5/12/2024 | Exercise of Stock Option Cash | 4.50K | — |
| Total | 12.50K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
12.50K
Market value
$287.6K
4/15/2026
—Completed
Units to sell
12.50K
Market value
$245.7K
3/16/2026
—Completed
Units to sell
17.39K
Market value
$315.9K
3/3/2026
—Completed
Units to sell
3.63K
Market value
$69.1K
2/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
12.50K
Market value
$253.9K
5/15/2026
Total
Units
58.52K
Value
$1.17M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/15/2026 | 12.50K | $287.6K | — | Completed |
3/16/2026 | 12.50K | $245.7K | — | Completed |
3/3/2026 | 17.39K | $315.9K | — | Completed |
2/25/2026 | 3.63K | $69.1K | — | Completed |
| Planned — Approximate Date | ||||
5/15/2026 | 12.50K | $253.9K | NASDAQ | Planned |
| Total | 58.52K | $1.17M | ||